Neoxpert Expanded Screening Panel Test (Newborn Screening 48+ Analytes) in Santacruz
51+ booked in last 3 daysNewborn Screening Test Overview
Newborn babies may be afflicted by a variety of conditions including cystic fibrosis, hereditary disorders, haemoglobinopathies, and inherited metabolic disorders (IMDs) from birth. IMDs are brought on by a gene abnormality that causes an enzyme deficit. Therefore, screening is crucial to identify potential fetal problems in newborns as quickly as possible, well before they show any symptoms of the disorder. Early diagnosis enables prompt treatment, which lessens the condition's negative effects.Newborn screening offers one such comprehensive screening method.
NBS, or newborn screening, is commonly referred to as the "baby's first test." Many newborn babies have a minor heel puncture around day two through either voluntary or required programs, and a few drops of blood are collected. This is sent to a diagnostic lab to examine for more than 40 extremely rare illnesses known as inborn metabolic errors. Aminoacidopathies, organic acidemias, fatty acid oxidation disorders, galactosemia, and biotinidase deficiency are among the conditions that can be detected with NBS.
Medically Reviewed by: Dr Alap Christy, MBBS, MD, PGDM-HC, Dept. of Clinical Chemistry
Neoxpert Expanded Screening Panel Test (Newborn Screening 48+ Analytes) Price in Santacruz
Metropolis Healthcare is a leading diagnostics centre and pathology lab in India equipped with the latest state-of-the-art technologies that provides the Neoxpert Expanded Screening Panel Test (Newborn Screening 48+ Analytes) with a clear pricing structure
The price of Neoxpert Expanded Screening Panel Test (Newborn Screening 48+ Analytes) in Santacruz is ₹ 6,360
We are committed to deliver accurate and quality results from the best labs in India with complete transparency regarding test cost and turnaround time. No matter where you are, we strive to offer patients high-quality service that is affordable and accessible.
Frequently Asked Questions
To identify babies at-risk for various inborn errors of metabolism.
This is a screening test for newborn babies usually done within 48-72 hours of birth to detect inborn errors of metabolism.
Newborn Screening is a test that involves testing of infants at birth for certain genetically linked metabolic disorders which may affect baby’s physical, mental and intellectual development. This is a combined panel which tests for 8 analytes viz TSH, G6PD and 17-OHP, Phenyl Alanine, Cystic Fibrosis, Galactosemia, Biotinidase and MSUD by FIA technology. This panel also tests for various analytes using Tandem Mass Spectrometry (TMS) that enables detection of multiple metabolic disorders with a single sample. Disorders that can be detected using TMS are various types of fatty acid, amino acid and organic acid related disorders.
Ratings & Reviews (0)
Why Metropolis?
Metropolis has a team of 200 senior pathologists and over 2000 technicians delivering diagnostic solutions in the areas of routine, semi specialty and super specialty domains like Oncology, Neurology, Gynaecology, Nephrology and many more.
We offer a comprehensive range of 4000+ clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of the disease.